Specialty Business Services
Compare Stocks
2 / 10Stock Comparison
ACTG vs FORM
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
ACTG vs FORM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Specialty Business Services | Semiconductors |
| Market Cap | $454M | $11.28B |
| Revenue (TTM) | $215M | $840M |
| Net Income (TTM) | $-18M | $68M |
| Gross Margin | 104.9% | 42.1% |
| Operating Margin | -18.7% | 12.7% |
| Forward P/E | 21.4x | 66.5x |
| Total Debt | $100M | $45M |
| Cash & Equiv. | $307M | $103M |
ACTG vs FORM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Acacia Research Cor… (ACTG) | 100 | 181.7 | +81.7% |
| FormFactor, Inc. (FORM) | 100 | 574.8 | +474.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ACTG vs FORM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ACTG has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.76
- Rev growth 133.2%, EPS growth 161.1%, 3Y rev CAGR 68.9%
- Lower volatility, beta 0.76, Low D/E 17.2%, current ratio 9.18x
FORM is the clearest fit if your priority is long-term compounding.
- 19.5% 10Y total return vs ACTG's 2.5%
- 8.1% margin vs ACTG's -8.5%
- +387.8% vs ACTG's +53.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 133.2% revenue growth vs FORM's 2.8% | |
| Value | Lower P/E (21.4x vs 66.5x) | |
| Quality / Margins | 8.1% margin vs ACTG's -8.5% | |
| Stability / Safety | Beta 0.76 vs FORM's 2.02 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +387.8% vs ACTG's +53.3% | |
| Efficiency (ROA) | 5.6% ROA vs ACTG's -2.4%, ROIC 5.4% vs 1.2% |
ACTG vs FORM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ACTG vs FORM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
FORM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
FORM is the larger business by revenue, generating $840M annually — 3.9x ACTG's $215M. FORM is the more profitable business, keeping 8.1% of every revenue dollar as net income compared to ACTG's -8.5%. On growth, FORM holds the edge at +32.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $215M | $840M |
| EBITDAEarnings before interest/tax | -$8M | $152M |
| Net IncomeAfter-tax profit | -$18M | $68M |
| Free Cash FlowCash after capex | $52M | -$5M |
| Gross MarginGross profit ÷ Revenue | +104.9% | +42.1% |
| Operating MarginEBIT ÷ Revenue | -18.7% | +12.7% |
| Net MarginNet income ÷ Revenue | -8.5% | +8.1% |
| FCF MarginFCF ÷ Revenue | +24.4% | -0.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -56.4% | +32.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -164.0% | +2.2% |
Valuation Metrics
ACTG leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 21.4x trailing earnings, ACTG trades at a 90% valuation discount to FORM's 209.7x P/E. On an enterprise value basis, ACTG's 5.0x EV/EBITDA is more attractive than FORM's 100.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $454M | $11.3B |
| Enterprise ValueMkt cap + debt − cash | $248M | $11.2B |
| Trailing P/EPrice ÷ TTM EPS | 21.39x | 209.68x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 66.48x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 4.98x | 100.94x |
| Price / SalesMarket cap ÷ Revenue | 1.59x | 14.37x |
| Price / BookPrice ÷ Book value/share | 0.78x | 10.94x |
| Price / FCFMarket cap ÷ FCF | 7.75x | 960.69x |
Profitability & Efficiency
FORM leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
FORM delivers a 6.7% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-3 for ACTG. FORM carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to ACTG's 0.17x. On the Piotroski fundamental quality scale (0–9), ACTG scores 9/9 vs FORM's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -3.2% | +6.7% |
| ROA (TTM)Return on assets | -2.4% | +5.6% |
| ROICReturn on invested capital | +1.2% | +5.4% |
| ROCEReturn on capital employed | +0.9% | +6.1% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 4 |
| Debt / EquityFinancial leverage | 0.17x | 0.04x |
| Net DebtTotal debt minus cash | -$206M | -$58M |
| Cash & Equiv.Liquid assets | $307M | $103M |
| Total DebtShort + long-term debt | $100M | $45M |
| Interest CoverageEBIT ÷ Interest expense | -5.51x | 252.69x |
Total Returns (Dividends Reinvested)
FORM leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FORM five years ago would be worth $37,395 today (with dividends reinvested), compared to $7,908 for ACTG. Over the past 12 months, FORM leads with a +387.8% total return vs ACTG's +53.3%. The 3-year compound annual growth rate (CAGR) favors FORM at 72.9% vs ACTG's 6.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +25.8% | +144.4% |
| 1-Year ReturnPast 12 months | +53.3% | +387.8% |
| 3-Year ReturnCumulative with dividends | +19.7% | +417.3% |
| 5-Year ReturnCumulative with dividends | -20.9% | +273.9% |
| 10-Year ReturnCumulative with dividends | +2.5% | +1952.2% |
| CAGR (3Y)Annualised 3-year return | +6.2% | +72.9% |
Risk & Volatility
Evenly matched — ACTG and FORM each lead in 1 of 2 comparable metrics.
Risk & Volatility
ACTG is the less volatile stock with a 0.76 beta — it tends to amplify market swings less than FORM's 2.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.76x | 2.02x |
| 52-Week HighHighest price in past year | $5.27 | $159.09 |
| 52-Week LowLowest price in past year | $3.03 | $26.08 |
| % of 52W HighCurrent price vs 52-week peak | +89.3% | +90.9% |
| RSI (14)Momentum oscillator 0–100 | 57.4 | 66.5 |
| Avg Volume (50D)Average daily shares traded | 343K | 1.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates ACTG as "Buy" and FORM as "Hold".
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | — | $123.38 |
| # AnalystsCovering analysts | 7 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% |
FORM leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ACTG leads in 1 (Valuation Metrics). 1 tied.
ACTG vs FORM: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ACTG or FORM a better buy right now?
For growth investors, Acacia Research Corporation (ACTG) is the stronger pick with 133.
2% revenue growth year-over-year, versus 2. 8% for FormFactor, Inc. (FORM). Acacia Research Corporation (ACTG) offers the better valuation at 21. 4x trailing P/E, making it the more compelling value choice. Analysts rate Acacia Research Corporation (ACTG) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ACTG or FORM?
On trailing P/E, Acacia Research Corporation (ACTG) is the cheapest at 21.
4x versus FormFactor, Inc. at 209. 7x.
03Which is the better long-term investment — ACTG or FORM?
Over the past 5 years, FormFactor, Inc.
(FORM) delivered a total return of +273. 9%, compared to -20. 9% for Acacia Research Corporation (ACTG). Over 10 years, the gap is even starker: FORM returned +1952% versus ACTG's +2. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ACTG or FORM?
By beta (market sensitivity over 5 years), Acacia Research Corporation (ACTG) is the lower-risk stock at 0.
76β versus FormFactor, Inc. 's 2. 02β — meaning FORM is approximately 168% more volatile than ACTG relative to the S&P 500. On balance sheet safety, FormFactor, Inc. (FORM) carries a lower debt/equity ratio of 4% versus 17% for Acacia Research Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — ACTG or FORM?
By revenue growth (latest reported year), Acacia Research Corporation (ACTG) is pulling ahead at 133.
2% versus 2. 8% for FormFactor, Inc. (FORM). On earnings-per-share growth, the picture is similar: Acacia Research Corporation grew EPS 161. 1% year-over-year, compared to -22. 5% for FormFactor, Inc.. Over a 3-year CAGR, ACTG leads at 68. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ACTG or FORM?
Acacia Research Corporation (ACTG) is the more profitable company, earning 7.
6% net margin versus 6. 9% for FormFactor, Inc. — meaning it keeps 7. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FORM leads at 8. 2% versus 2. 2% for ACTG. At the gross margin level — before operating expenses — ACTG leads at 82. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — ACTG or FORM?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is ACTG or FORM better for a retirement portfolio?
For long-horizon retirement investors, Acacia Research Corporation (ACTG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
76)). FormFactor, Inc. (FORM) carries a higher beta of 2. 02 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACTG: +2. 5%, FORM: +1952%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ACTG and FORM?
These companies operate in different sectors (ACTG (Industrials) and FORM (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ACTG is a small-cap high-growth stock; FORM is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.